AmebaGone is fighting antimicrobial resistance with a novel technology.

Antimicrobial resistance poses a serious challenge to modern medicine, especially in intractable infections where bacteria often persist in antimicrobial-tolerant biofilms that conventional antibiotics can't penetrate. Our technology turns anti-biofilm compounds produced by Dictyostelids into a novel solution for treating biofilm-associated infections. By harnessing these natural predators and their evolved ability to hunt and consume microbes within biofilms, we introduce a new tool to reduce antibiotic resistance and address the rising threat of drug-resistant infections.

Get to know the talented individuals behind our success. At AmebaGone, our diverse team brings together expertise across science, medicine, and agriculture - backed by deep specialization in amoebic biocontrol. United by a shared mission, we're developing disruptive technology that challenges the conventional use of antibiotics and drives forward a safer, more effective approach to microbial control.